ImmunisLogoWImmunisLogocropped-immunislogo.pngcropped-immunislogo.png
  • Home
  • About Us
    • Mission
    • Technology
    • Leadership
  • Resources
    • About secretome biologics
    • About IMM01-STEM
    • About sarcopenia
    • Interested in a clinical trial?
  • Pipeline
    • STEM-MYO Program
      • Phase 1/2a Clinical Trial
    • STEM-META Program
      • Phase 2 Clinical Trial
  • News
    • Awards
    • Media
    • Press Releases
  • Contact
✕

Header-bio

Sarcopenia: Causes, Consequences, and Interventions

What is sarcopenia?

Who does it affect?

What are the symptoms?

What are the causes?

How is it diagnosed?

Is there a treatment?

Sarcopenia and frailty

Sarcopenia and obesity

Muscle and healthspan

Recent News

  • Jan 14, 2026

    Immunis Announces Preliminary Results from First-Ever Phase 2 Study of a Secretome-Based Biologic Showing Improved Gait Speed in Obese Sarcopenic Seniors

  • Nov 20, 2025

    Immunis Named by The Healthcare Technology Report as one of the “Top 50 Healthcare Technology Companies of 2025”

  • Oct 31, 2025

    Immunis Publishes Research Showing Body Fat Loss and Reversal of Liver Steatosis and Fibrosis, While Increasing Lean Muscle Mass

Navigation

  • Home
  • About Us
    • Mission
    • Technology
    • Leadership
  • Resources
    • About secretome biologics
    • About IMM01-STEM
    • About sarcopenia
    • Interested in a clinical trial?
  • Pipeline
    • STEM-MYO Program
      • Phase 1/2a Clinical Trial
    • STEM-META Program
      • Phase 2 Clinical Trial
  • News
    • Awards
    • Media
    • Press Releases
  • Contact

Contact info

Immunis, Inc.
Irvine, California


contact@immunisbiomedical.com

Copyright © 2026 Immunis, Inc.